A highly productive July and August for Barts Cancer Institute

3 August 2015

Source: Cancer Research UK

A new study by researchers at Barts Cancer Institute have uncovered a biomarker for pancreatic cancer in patients' urine, paving the way for a low-cost, non-invasive test that could diagnose the disease in its early stages.  Lead researcher Dr. Tatjana Crnogorac-Jurcevic and colleagues publish their findings in the journal Clinical Cancer Research.

Paper is entitled Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. 

29 July 2015 

Source: Barts Cancer Institute

Professor Louise Jones has been appointed Clinical Lead for Molecular Pathology in the Genomics England 100.000 Genomes Project.

16 July 2015 

Source: Barts Cancer Institute

Dr Trevor Graham, Centre for Tumour Biology received a Career Development Award of approximately £1m from Cancer Research UK to study the evolution of human colorectal cancer. 

14 July 2015 

Source: Barts Cancer Institute

Two new papers from the Centre for Haemato-Oncology in the journal Blood show that boosting the immune system could help control Chronic Lymphocytic Leukaemia (CLL). Centre Lead, Prof John Gribben, said: “This is the very first time that this approach has been explored in the context of CLL. “Our findings therefore provide a strong rationale for further clinical assessment of PD-1/PD-L1 immune checkpoint blockade in CLL, and clinical trials using this approach are now under way.”

7 July 2015 

Source: Barts Cancer Institute

Professor Kairbaan Hodivala-Dilke, Centre for Tumour Biology has been awarded a new £2.3m grant from Cancer Research UK to investigate the role of tumour blood vessels in how solid cancer responds to treatment.